Search results
Results from the WOW.Com Content Network
For example, in Railway Executives, the need to discover the cause of railway accidents justified the drug testing, and in Acton it was the need to promote a drug-free school environment. In this case, however, the very reason for the policy was to use the threat of arrest to motivate the women to abstain from using cocaine.
The FRA also adopted regulations that authorized railroads to administer breath and urine drug tests to employees who violated safety rules. The Railway Labor Executives' Association , an umbrella group of railway trade unions , sued to have the regulations declared an unconstitutional violation of the Fourth Amendment to the United States ...
The protocol of the random drug testing program the district initiated was straightforward. All student athletes would be required to submit to the program as a condition of participating in athletics. All athletes were tested at the beginning of the season, and 10% of the athletes were selected randomly every week to provide a urine sample.
Unable to afford to fight these claims, another non-profit member that operates in Southern California settled a PAGA lawsuit for $335,000. The plaintiffs’ attorneys received $195,000, while ...
Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco County, 582 U.S. ___ (2017), was a United States Supreme Court case in which the Court held that California courts lacked personal jurisdiction over the defendant on claims brought by plaintiffs who are not California residents and did not suffer their alleged injury in California. [1]
A new law requiring many California bars and nightclubs to offer common date-rape drug test kits will take effect Tuesday, according to the California Department of Alcoholic Beverage Control.
The drugmaker has settled a series of lawsuits related to Zantac over the past 12 months, including several in California. California is generally seen as a more challenging legal environment for ...
On December 9, 2016, pharmaceutical company Bristol-Myers Squibb agreed to pay $19.5 million to settle claims with forty-three state attorneys general concerning the alleged off-label promotion of its schizophrenia drug Abilify. [50] The lawsuit alleged the company promoted the drug for use in pediatric populations and to treat dementia and ...